Published in Infect Immun on November 01, 1990
Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci U S A (2000) 2.11
A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J Exp Med (2004) 1.81
The role of phosphoglycans in Leishmania-sand fly interactions. Proc Natl Acad Sci U S A (2000) 1.68
Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med (1997) 1.54
Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc Natl Acad Sci U S A (1993) 1.36
Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J (2000) 1.23
Membrane vesicles shed by Legionella pneumophila inhibit fusion of phagosomes with lysosomes. Infect Immun (2006) 1.20
The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. PLoS Pathog (2009) 1.11
The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation. Infect Immun (1994) 1.00
Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. Proc Natl Acad Sci U S A (1996) 0.97
A novel role for Stat1 in phagosome acidification and natural host resistance to intracellular infection by Leishmania major. PLoS Pathog (2009) 0.95
Leishmania promastigotes: building a safe niche within macrophages. Front Cell Infect Microbiol (2012) 0.90
Trafficking and release of Leishmania metacyclic HASPB on macrophage invasion. Cell Microbiol (2012) 0.88
Structural characterization and epitope mapping of the glutamic acid/alanine-rich protein from Trypanosoma congolense: defining assembly on the parasite cell surface. J Biol Chem (2011) 0.88
Inhibition of CD1 expression in human dendritic cells during intracellular infection with Leishmania donovani. Infect Immun (2004) 0.87
Leishmania major MPK7 protein kinase activity inhibits intracellular growth of the pathogenic amastigote stage. Eukaryot Cell (2009) 0.87
The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasi. Mol Biochem Parasitol (2007) 0.86
Lipophosphoglycan from Leishmania suppresses agonist-induced interleukin 1 beta gene expression in human monocytes via a unique promoter sequence. Proc Natl Acad Sci U S A (1996) 0.84
Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate? Front Cell Infect Microbiol (2015) 0.84
Innate immune activation and subversion of Mammalian functions by leishmania lipophosphoglycan. J Parasitol Res (2012) 0.82
A simple method of reducing the fading of immunofluorescence during microscopy. J Immunol Methods (1981) 10.77
Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells. J Immunol (1981) 4.27
New culture medium for maintenance of tsetse tissues and growth of trypanosomatids. J Protozool (1977) 2.91
The Leishmania receptor for macrophages is a lipid-containing glycoconjugate. EMBO J (1985) 2.24
Procyclin: an unusual immunodominant glycoprotein surface antigen from the procyclic stage of African trypanosomes. Mol Biochem Parasitol (1988) 2.01
Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol Today (1989) 1.97
Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J Biol Chem (1987) 1.89
Leishmania donovani: promastigote--macrophage surface interactions in vitro. Exp Parasitol (1979) 1.79
Leishmanial serotypes as distinguished by the gel diffusion of factors excreted in vitro and in vivo. Isr J Med Sci (1972) 1.64
The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol Biochem Parasitol (1989) 1.40
Leishmania donovani: surface membrane carbohydrates of promastigotes. Exp Parasitol (1977) 1.39
Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan. Biochemistry (1987) 1.31
Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells. Infect Immun (1989) 1.30
Leishmania and the macrophage: a marriage of inconvenience. Immunol Today (1989) 1.29
Expression of Leishmania antigen on the surface membrane of infected human macrophages in vitro. Clin Exp Immunol (1981) 1.19
Trypanosome variant surface glycoprotein transfer to target membranes: a model for the pathogenesis of trypanosomiasis. Proc Natl Acad Sci U S A (1990) 1.16
Structure of the phosphosaccharide-inositol core of the Leishmania donovani lipophosphoglycan. J Biol Chem (1989) 1.14
Procyclic tsetse fly midgut forms and culture forms of African trypanosomes share stage- and species-specific surface antigens identified by monoclonal antibodies. J Immunol (1986) 1.13
The leishmanial lipophosphoglycan: a multifunctional molecule. Exp Parasitol (1990) 1.04
Scanning electron-microscopic study of the uptake of Leishmania parasites by macrophages. J Cell Sci (1979) 0.96
Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect Immun (1989) 0.95
T-lymphocytes recognise Leishmania glycoconjugates. Parasitol Today (1985) 0.94
Antigen presentation and the response to parasitic infection. Parasitol Today (1987) 0.91
Identification and recovery of Leishmania antigen displayed on the surface membrane of mouse peritoneal macrophages infected in vitro. J Immunol (1986) 0.91
A permanent wet-mount for fluorescent microscopy of surface stained lymphoid cells. J Immunol Methods (1984) 0.86
The lipophosphoglycan of Leishmania. Parasitol Today (1988) 0.83
Proposal for a common oligosaccharide intermediate in the synthesis of membrane glycoproteins. Cell (1977) 4.77
Procyclin gene expression and loss of the variant surface glycoprotein during differentiation of Trypanosoma brucei. J Cell Biol (1989) 2.60
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21
Use of the green fluorescent protein as a marker in transfected Leishmania. Mol Biochem Parasitol (1996) 2.19
Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc Natl Acad Sci U S A (2000) 2.11
Procyclin: an unusual immunodominant glycoprotein surface antigen from the procyclic stage of African trypanosomes. Mol Biochem Parasitol (1988) 2.01
Stage-specific adhesion of Leishmania promastigotes to the sandfly midgut. Science (1992) 1.99
Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J Biol Chem (1987) 1.89
Synchronous differentiation of Trypanosoma brucei from bloodstream to procyclic forms in vitro. Eur J Biochem (1990) 1.79
Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin. Science (2001) 1.77
Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J (1992) 1.75
The role of phosphoglycans in Leishmania-sand fly interactions. Proc Natl Acad Sci U S A (2000) 1.68
Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol (1998) 1.58
Glycoconjugates in Leishmania infectivity. Biochim Biophys Acta (1999) 1.53
Evidence that the vectorial competence of phlebotomine sand flies for different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc Natl Acad Sci U S A (1994) 1.52
Structure and assembly of the endoplasmic reticulum. Biosynthetic sorting of endoplasmic reticulum proteins. J Biol Chem (1985) 1.50
Methods for derivation and detection of anti-parasite monoclonal antibodies. J Immunol Methods (1980) 1.49
Cell-mediated immunity to Theileria-transformed cell lines. Nature (1979) 1.48
Dual role of the fringe connection gene in both heparan sulphate and fringe-dependent signalling events. Nat Cell Biol (2001) 1.46
Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages. J Immunol (1991) 1.46
A specialized pathway affecting virulence glycoconjugates of Leishmania. Science (1995) 1.45
Galactofuranose metabolism: a potential target for antimicrobial chemotherapy. Cell Mol Life Sci (2003) 1.45
Comparative rates of transfer of lipid-linked oligosaccharides to endogenous glycoprotein acceptors in vitro. Proc Natl Acad Sci U S A (1977) 1.44
Expression of an unusual acidic glycoconjugate in Leishmania donovani. J Biol Chem (1984) 1.44
A ricin agglutinin-resistant clone of Leishmania donovani deficient in lipophosphoglycan. Mol Biochem Parasitol (1988) 1.44
Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J Biol Chem (1997) 1.43
The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol Biochem Parasitol (1989) 1.40
Characterization of developmentally-regulated activities in axenic amastigotes of Leishmania donovani. Mol Biochem Parasitol (1998) 1.38
Phlebitis associated with intravenous drug administration. Bull Parenter Drug Assoc (1975) 1.37
Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc Natl Acad Sci U S A (1993) 1.36
Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J Immunol (1992) 1.32
Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J Exp Med (1995) 1.30
Immune depression in trypanosome-infected mice. I. Depressed T lymphocyte responses. Eur J Immunol (1978) 1.30
Apoptosis in procyclic Trypanosoma brucei rhodesiense in vitro. Cell Death Differ (1996) 1.27
Glycoconjugate structures of parasitic protozoa. Glycobiology (2001) 1.26
Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis. Mol Biochem Parasitol (1991) 1.24
The bovine lymphoid system: binding and stimulation of peripheral blood lymphocytes by lectins. J Immunol Methods (1979) 1.22
Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J Immunol (1990) 1.22
Refined structure of the lipophosphoglycan of Leishmania donovani. J Biol Chem (1992) 1.21
Cell surface lipophosphoglycan of Leishmania donovani. Mol Biochem Parasitol (1987) 1.16
Immune depression in trypanosome-infected mice. III. suppressor cells. Eur J Immunol (1979) 1.15
Arrangement of glucose residues in the lipid-linked oligosaccharide precursor of asparaginyl oligosaccharides. J Biol Chem (1979) 1.14
Identification and characterization of an acidic major surface glycoprotein from procyclic stage Trypanosoma congolense. Mol Biochem Parasitol (1993) 1.14
Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan. Biochem Biophys Res Commun (1987) 1.14
Procyclic tsetse fly midgut forms and culture forms of African trypanosomes share stage- and species-specific surface antigens identified by monoclonal antibodies. J Immunol (1986) 1.13
Stable DNA transfection of a wide range of trypanosomatids. Mol Biochem Parasitol (1991) 1.10
Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania. Biochem J (1989) 1.09
The Leishmania GDP-mannose transporter is an autonomous, multi-specific, hexameric complex of LPG2 subunits. Biochemistry (2000) 1.09
Deficiency in beta1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. J Biol Chem (1996) 1.07
Modification of oligosaccharide-lipid synthesis and protein glycosylation in glucose-deprived cells. Arch Biochem Biophys (1980) 1.05
The procyclin coat of African trypanosomes (or the not-so-naked trypanosome). Parasitol Today (1990) 1.04
The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. J Immunol (1991) 1.03
The role of the lipophosphoglycan of Leishmania in vector competence. Parasitology (1994) 1.03
Cell-free biosynthesis of lipophosphoglycan from Leishmania donovani. Characterization of microsomal galactosyltransferase and mannosyltransferase activities. J Biol Chem (1991) 1.02
Defective galactofuranose addition in lipophosphoglycan biosynthesis in a mutant of Leishmania donovani. J Biol Chem (1993) 1.02
Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions. Biochemistry (1999) 1.02
Immune depression in trypanosome-infected mice. II. Characterization of the spleen cell types involved. Eur J Immunol (1979) 1.01
Lipophosphoglycan expression and virulence in ricin-resistant variants of Leishmania major. Mol Biochem Parasitol (1990) 1.01
Solution structure of the lipophosphoglycan of Leishmania donovani. Biochemistry (1992) 1.00
The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation. Infect Immun (1994) 1.00
Phosphorylation of a major GPI-anchored surface protein of Trypanosoma brucei during transport to the plasma membrane. J Cell Sci (1999) 0.99
Immune depression in trypanosome-infected mice. IV. Kinetics of suppression and alleviation by the trypanocidal drug Berenil. Clin Exp Immunol (1979) 0.99
Activation of human immunodeficiency virus type 1 in monocytoid cells by the protozoan parasite Leishmania donovani. J Virol (1995) 0.98
Effect of glycolipids of Leishmania parasites on human monocyte activity. Inhibition by lipophosphoglycan. J Immunol (1990) 0.98
Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J Immunol (1992) 0.98
Nuclear sodium and potassium. Nature (1981) 0.97
The initial stages of processing of protein-bound oligosaccharides in vitro. J Biol Chem (1979) 0.97
Presence of erythroglycan on human K-562 chronic myelogenous leukemia-derived cells. J Biol Chem (1980) 0.97
Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani. Proc Natl Acad Sci U S A (1996) 0.97
Studies on the induction and specificity of cytotoxicity to Theileria-transformed cell lines. J Immunol (1982) 0.97
Intracellular monosaccharide and amino acid concentrations and activities and the mechanisms of insulin action. Mol Cell Biol (1981) 0.96
The lipophosphoglycan of Leishmania and macrophage protein kinase C. Parasitol Today (1993) 0.96
Phosphatidylinositol-anchored molecules and inducible lipopolysaccharide binding sites of human and mouse bone marrow cells. J Biol Chem (1994) 0.95
Potent inhibition of viral fusion by the lipophosphoglycan of Leishmania donovani. Biochemistry (1995) 0.95
Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites. Mol Biochem Parasitol (1995) 0.95
An avirulent lipophosphoglycan-deficient Leishmania major clone induces CD4+ T cells which protect susceptible BALB/c mice against infection with virulent L. major. Infect Immun (1993) 0.94
Rapid separation of high-mannose-type oligosaccharides by high-pressure liquid chromatography. Anal Biochem (1981) 0.94
Analysis of Kudoa thyrsites (Myxozoa: Myxosporea) spore antigens using monoclonal antibodies. Dis Aquat Organ (2001) 0.93
Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. J Immunol (1991) 0.93
The bovine lymphoid system: II. Derivation and partial characterlzation of monoclonal antibodies against bovine peripheral blood lymphocytes. Vet Immunol Immunopathol (1980) 0.93
Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. Int J Parasitol (2010) 0.92
Expression of GARP, a major surface glycoprotein of Trypanosoma congolense, on the surface of Trypanosoma brucei: characterization and use as a selectable marker. Mol Biochem Parasitol (1995) 0.92
Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense. Immunology (1986) 0.92
Purification and characterization of an extracellular phosphoglycan from Leishmania donovani. J Biol Chem (1992) 0.92
Biosynthesis of lipophosphoglycan from Leishmania donovani: characterization of mannosylphosphate transfer in vitro. Arch Biochem Biophys (1992) 0.91
Designing glycoconjugate biosynthesis for an insidious intent: phosphoglycan assembly in Leishmania parasites. Glycobiology (1997) 0.91
Structural features of antigenic determinants on variant surface glycoproteins from Trypanosoma brucei. Mol Immunol (1987) 0.91
Demonstration of sialyltransferase deficiency in the serum of a patient with alpha-1-antitrypsin deficiency and hepatic cirrhosis. Lab Invest (1974) 0.91
Identification and isolation of a variant surface glycoprotein from Trypanosoma vivax. Science (1987) 0.90
Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies. Glycobiology (1990) 0.89
Reversion to virulence in Leishmania major correlates with expression of surface lipophosphoglycan. Mol Biochem Parasitol (1993) 0.89
Increased expression of unusual EP repeat-containing proteins in the midgut of the tsetse fly (Glossina) after bacterial challenge. Insect Biochem Mol Biol (2005) 0.89
Use of high-resolution two-dimensional gel electrophoresis for analysis of monoclonal antibodies and their specific antigens. Methods Enzymol (1983) 0.88
Leishmania donovani possess a NADPH-dependent alkylglycerol cleavage enzyme. Biochem Biophys Res Commun (1996) 0.88
Trypanosome variable surface antigens: studies using two-dimensional gel electrophoresis and monoclonal antibodies. J Immunol (1981) 0.88
Comparison of African trypanosomes of different antigenic phenotypes, subspecies and life cycle stages by two-dimensional gel electrophoresis. Mol Biochem Parasitol (1985) 0.88